Explore Jobs
Find Specific Jobs
Explore Careers
Explore Professions
Best Companies
Explore Companies
CRISPR Therapeutics history
CRISPR Therapeutics company history timeline
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., et al. (2013). Multiplex genome engineering using CRISPR/Cas systems.
For a narrative perspective of the history of CRISPR research, read "The Heroes of CRISPR," by Eric S. Lander, in the January 14, 2016 edition of Cell.
In 2016, the company went public on NASDAQ. In August 2016 the company started to operate Casebia Therapeutics, as a joint venture with Bayer.
In 2019, Casebia Therapeutics came directly under the control of CRISPR Therapeutics.
One of the co-founders Emmanuelle Charpentier later shared the Nobel Prize in Chemistry in 2020 with Jennifer Doudna.
Rate CRISPR Therapeutics' efforts to communicate its history to employees.
CRISPR Therapeutics jobs
Do you work at CRISPR Therapeutics?
Does CRISPR Therapeutics communicate its history to new hires?
CRISPR Therapeutics competitors
Company Name  | Founded Date | Revenue | Employee Size | Job Openings |
|---|---|---|---|---|
| Rigel Pharmaceuticals | 1996 | $120.2M | 158 | 5 |
| Ardelyx | 2007 | $52.2M | 86 | 42 |
| VBI Vaccines | 2001 | $1.0M | 22 | - |
| Tango Therapeutics | 2017 | $24.9M | 91 | 9 |
| eFFECTOR Therapeutics | 2012 | $3.6M | 24 | - |
| Synlogic | 2014 | $1.2M | 74 | - |
| Mersana Therapeutics | 2001 | $26.6M | 169 | - |
| IDEAYA Biosciences | 2015 | $50.9M | 69 | 38 |
CRISPR Therapeutics history FAQs
Zippia gives an in-depth look into the details of CRISPR Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about CRISPR Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at CRISPR Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by CRISPR Therapeutics. The data presented on this page does not represent the view of CRISPR Therapeutics and its employees or that of Zippia.
CRISPR Therapeutics may also be known as or be related to CRISPR THERAPEUTICS AG, CRISPR Therapeutics, CRISPR Therapeutics AG, Crispr Therapeutics and Crispr Therapeutics, Inc.